Amerigo Scientific, a distribution company focused on providing critical products and services to the biomedical and life science research communities, now introduces hydroxyapatite for 3D Bioprinting. This material powder can be incorporated in different bioinks for hard tissue engineering.
STEMart introduces multiple medical device genetic toxicology testing services following the OECD guidelines modified for medical devices and performing under GLP conditions.
Amerigo Scientific launches AcrB transporter that aids in the identification, development, refinement, and validation of new molecules and therapeutic antibodies.
With years of experience in the pharmaceutical and life science sector, Creative Diagnostics introduces a series of PEI PLGA Nanoparticles for gene delivery and gene therapy, which are based on poly(lactide-co-glycolide) acid terminated with a lactide/glycolide ratio of 50/50 and a molecular weight of 32000 Da. These nanoparticles are positively charged due to the surface modification with PEI.
CD Bioparticles expands its Metal Organic Frameworks (MOFs) materials portfolio with the launch of Zinc-based MOFs (Fe-MOF) to support drug delivery studies for the research communities.
Amerigo Scientific recently launches 3D Graphene for printing electrically stimulated tissues such as cardiac, skeletal muscle and nerve, as well as biocompatible circuits.
Delaware has launched a pilot grant program designed to spur private sector-led projects that will help the state attract and retain science and tech companies by expanding its inventory of ready-to-go lab space.
Feeling delightful to announce our upcoming conference “Euro-Global Conference on Biotechnology and Bioengineering” (ECBB 2021) during September 06-08, 2021 which is going to held at Rome, Italy.
Satisfied Users & 
Approved Press Releases
